Detalhe da pesquisa
1.
Association of plasma NRP2 and VEGF-C levels with prostate cancer disease severity.
Prostate
; 84(3): 277-284, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942701
2.
Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(3): 140-150, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626801
3.
A case of metastatic adenoid cystic (basal cell) carcinoma of the prostate: Systemic therapy for a rare disease.
Prostate
; 83(8): 814-819, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967482
4.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856213
5.
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
J Natl Compr Canc Netw
; 20(12): 1288-1298, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509074
6.
Impact of Proton Pump Inhibitor Use on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Cancer Patients.
Ann Pharmacother
; 56(4): 377-386, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282636
7.
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 19(2): 134-143, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545689
8.
Current Management of Refractory Germ Cell Tumors.
Curr Oncol Rep
; 23(9): 101, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269906
9.
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302.
Prostate
; 79(8): 929-933, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31059588
10.
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Lancet Oncol
; 19(1): 76-86, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248236
11.
Chemotherapy options in castration-resistant prostate cancer.
Indian J Urol
; 32(4): 262-270, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843207
12.
Identification and management of toxicities from immune checkpoint-blocking drugs.
Oncology (Williston Park)
; 28 Suppl 3: 30-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25384885
13.
Diagnosis of Metastatic Non-Small Cell Lung Cancer during Hospitalization: Missed Opportunity for Optimal Supportive Care?
Cancers (Basel)
; 16(6)2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539553
14.
Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer.
Radiat Oncol J
; 41(3): 154-162, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793624
15.
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TßRI expression.
Cancer Lett
; 579: 216468, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940068
16.
The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinations.
Expert Rev Clin Pharmacol
; 15(11): 1293-1304, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36285641
17.
Impact of Performance Status on Response and Survival Among Patients Receiving Checkpoint Inhibitors for Advanced Solid Tumors.
JCO Oncol Pract
; 18(1): e175-e182, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351819
18.
Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance.
Cell Rep
; 40(3): 111097, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858551
19.
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.
Proc Natl Acad Sci U S A
; 105(7): 2586-91, 2008 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18272481
20.
Biomarkers for Treatment Response in Advanced Prostate Cancer.
Cancers (Basel)
; 13(22)2021 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830878